Home

Insights

PE

ANG Lifesciences India Ltd P/E Ratio

ANG Lifesciences India Ltd P/E Ratio

download
stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

3.7 K

stocks traded

Last Updated time: 13 Jul 15:30 PM

Image

ANG Lifesciences India Ltd

NSE: ANGLIFESCIENCES

PE

0

Last updated : 13 Jul 15:30 PM

Key Highlights

    The P/E Ratio of ANG Lifesciences India Ltd is 0 as of 13 Jul 15:30 PM .a1#The P/E Ratio of ANG Lifesciences India Ltd changed from 6 on March 2022 to 0 on March 2023 . This represents a CAGR of -100.00% over 2 years. a1#The Latest Trading Price of ANG Lifesciences India Ltd is ₹ 52.2 as of 12 Jul 15:30 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.5 to 27.2 in 5 years. This represents a CAGR of -0.93%a1# The PE Ratio of Automobile industry is 17.2. The PE Ratio of Finance industry is 24.7. The PE Ratio of IT - Software industry is 29.2. The PE Ratio of Pharmaceuticals industry is 37.5. The PE Ratio of Retail industry is 143.1. The PE Ratio of Textiles industry is 12.1. In 2024a1#The Market Cap of ANG Lifesciences India Ltd changed from ₹ 243.2 crore on March 2022 to ₹ 99.31 crore on March 2023 . This represents a CAGR of -36.10% over 2 years. a1#The Revenue of ANG Lifesciences India Ltd changed from ₹ 73.8 crore to ₹ 38.03 crore over 8 quarters. This represents a CAGR of -28.21% a1#The EBITDA of ANG Lifesciences India Ltd changed from ₹ 12.1 crore to ₹ 1.81 crore over 8 quarters. This represents a CAGR of -61.32% a1#The Net Pr of ANG Lifesciences India Ltd changed from ₹ 3.49 crore to ₹ -3.65 crore over 8 quarters. This represents a CAGR of NaN% a1#The Dividend Payout of ANG Lifesciences India Ltd changed from 2.61 % on March 2019 to 0 % on March 2023 . This represents a CAGR of -100.00% over 2 years. a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

×

Historical P/E Ratio of ANG Lifesciences India Ltd

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Historical P/E Ratio of ANG Lifesciences India Ltd

Period
Mar '226
Mar '230

Company Fundamentals for ANG Lifesciences India Ltd

Market Cap

68 Cr

EPS

0.0

P/E Ratio (TTM) *

0.0

P/B Ratio (TTM) *

0.9

Day’s High

53.35

Day’s Low

52.04

DTE *

1.0

ROE *

-11.0

52 Week High

86.06

52 Week Low

44.49

ROCE *

1.3

* All values are consolidated

Last Updated time: 13 Jul 15:30 PM

* All values are consolidated

Last Updated time: 13 Jul 15:30 PM

Image

ANG Lifesciences India Ltd

NSE: ANGLIFESCIENCES

PRICE

52.2

-0.06 (-0.11%)

stock direction

Last updated : 12 Jul 15:30

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of ANG Lifesciences India Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

Asset Value vs Market Value of ANG Lifesciences India Ltd

Market Value

68

-0.6 X

Value addition

Asset Value

193

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
ANG Lifesciences India Ltd068
Sun Pharmaceuticals Industries Ltd37378,675
Cipla Ltd28122,093
Divis Laboratories Ltd75120,480
Zydus Lifesciences Ltd30118,217
Dr Reddys Laboratories Ltd20112,137

Key Valuation Metric of ANG Lifesciences India Ltd

Earnings

-10 Cr

0.0 X

PE Ratio

Market Cap

₹68.16Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Earnings

-10 Cr

0.0 X

PE Ratio

Market Cap

₹68.16Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

×

Historical Market Cap of ANG Lifesciences India Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of ANG Lifesciences India Ltd

Period
Mar '22243
Mar '2399

* All values are a in crore

×

Historical Revenue of ANG Lifesciences India Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of ANG Lifesciences India Ltd

Period
Jun '2274
Sep '2260
Dec '2247
Mar '2349
Jun '2357
Sep '2333
Dec '2319
Mar '2438

* All values are a in crore

×

Historical EBITDA of ANG Lifesciences India Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of ANG Lifesciences India Ltd

Period
Jun '2212
Sep '2210
Dec '223
Mar '23-1
Jun '237
Sep '232
Dec '23-2
Mar '242

* All values are a in crore

×

Historical Net Profit of ANG Lifesciences India Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of ANG Lifesciences India Ltd

Period
Jun '223
Sep '223
Dec '22-2
Mar '23-5
Jun '232
Sep '23-2
Dec '23-6
Mar '24-4

* All values are a in crore

×

Historical Dividend Payout of ANG Lifesciences India Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of ANG Lifesciences India Ltd

Period
Mar '190
Mar '200
Mar '210
Mar '223
Mar '230

* All values are a in %

About ANG Lifesciences India Ltd

About ANG Lifesciences India Ltd

    ANG Lifesciences India Limited was originally incorporated as a Private Limited Company with the name 'ANG Lifesciences India Private Limited' on June 14, 2006. On conversion into Public Limited Company, the name was changed to ANG Lifesciences India Limited on March 02, 2010. The Company further converted into Private Limited Company and the name of the Company was changed to 'ANG Lifesciences India Private Limited' on September 22, 2010. Subsequently, on conversion into Public Limited Company, the name again changed to 'ANG Lifesciences India Limited' on May 18, 2016. The Company is engaged in the business of manufacturing and marketing of finished pharmaceutical formulation in the form of Sterile Dry Powder Injection Vials. In 2008-09, the Company started its commercial production. In 2014-15, it commenced direct sale of medicines covering hospitals , Doctors through stockists. The Company is ISO-9001:2008 certified, which manufacture its products in compliance with GMP requirements. Company has dedicated area, machinery, facilities and advanced equipment for manufacturing of Beta Lactum & Non Beta Lactum products as per GMP norms. The Company currently operates a strong manufacturing set-up consisting of 4 formulation plants situated at Baddi, Himachal Pradesh. These state-of-art facilities have integrated process development teams with in-house engineering capabilities and well equipped with quality control laboratories with most modern and validate analytical equipment. It also has geographical presence across India, Africa, Gulf countries & other ROW countries. In August, 2017, the Company came up with a Public Issue of 15,00,800 Equity Shares by raising money from public aggregating to Rs 12 Crore. The Company acquired Mansa Printers & Publishers Limited in April, 2021 for backward integration in pharma packaging to optimize costs and ensure timely availability of packaging products.

ANG Lifesciences India Ltd News Hub

News

ANG Lifesciences India to discuss results

ANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 30 ...

Read more

29 May 202414:57

News

ANG Lifesciences India schedules board meeting

ANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 14 ...

Read more

09 Feb 202416:11

News

ANG Lifesciences India to declare Quarterly Result

ANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 14 ...

Read more

08 Nov 202311:49

News

ANG Lifesciences India to hold AGM

ANG Lifesciences India announced that the Annual General Meeting (AGM) of the company will...

Read more

12 Sep 202317:01

News

ANG Lifesciences India AGM scheduled

ANG Lifesciences India announced that the Annual General Meeting (AGM) of the company will...

Read more

12 Sep 202317:01

News

ANG Lifesciences India to conduct AGM

ANG Lifesciences India announced that the 17th Annual General Meeting (AGM) of the company...

Read more

08 Sep 202317:26

Product Composition by Percentage (Revenue)

FAQs for PE of ANG Lifesciences India Ltd

What is ANG Lifesciences India Ltd current share price?

The current market price of ANG Lifesciences India Ltd as of July 13, 2024 is ₹52.20.

What is ANG Lifesciences India Ltd's market cap?

ANG Lifesciences India Ltd's market capitalisation stood at ₹68 Cr as of July 13, 2024

What are ANG Lifesciences India Ltd's total net assets?

According to ANG Lifesciences India Ltd's most recent financial filings, the company's net assets total ₹192.5 Cr.

Is ANG Lifesciences India Ltd making a profit or loss?

ANG Lifesciences India Ltd's net Profit as of July 13, 2024 is close to ₹-10 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199